Purchases and Sales Made in Q4 2022 in Protagenic Therapeutics, Inc.New (PTIX)
This table provides information about the institutional ownership of Protagenic Therapeutics, Inc.New (PTIX) during Q4 2022. The information is specifically focused on institutions that hold shares of Protagenic Therapeutics, Inc.new.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Warberg Asset Management LLC
Winnetka, IL |
BUY
|
- |
20KNew |
$7K - $52K
|
20K
$12K
|
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
14KNew |
$4.89K - $36.3K
|
14K
$8.39K
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
BUY
|
- |
10.7K+ 164.83% |
$3.74K - $27.8K
|
17.2K
$10.3K
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
7.35K+ 45.58% |
$2.57K - $19.1K
|
23.5K
$14.1K
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
2+ 2.27% |
$0.7 - $5.2
|
90
$54
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1- 50.0% |
$0.35 - $2.6
|
1
$0.6
|
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-284- 0.27% |
$99.4 - $738
|
104K
$62.2K
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-321- 4.92% |
$112 - $835
|
6.21K
$3.72K
|
|
|
Feb 15, 2023
Q4 2022
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-470- 4.44% |
$165 - $1.22K
|
10.1K
$6.07K
|
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-16.5K- 6.53% |
$5.78K - $42.9K
|
236K
$142K
|